I hope we'll see a progress
'Biotechnology Victoria e-bulletin' - page 2
'On 9 September 2009, Phosphagenics Ltd (ASX: POH) announced it will start a Phase 2/3 trial of its patented TPM delivery system with the anti-inflammatory drug, diclofenac, in the first quarter of 2010.
The successful completion of the Phase 1B trial this week demonstrated that Phosphagenics' TPM delivery system was able to safely deliver a significantly greater amount of diclofenac into the skin compared to a leading commercial product, Voltaren'.
http://docs.google.com/viewer?a=v&q=cache:6DAbQ9QWUsAJ:www.ausbiotech.org/data/downloads/150909%2520Victorian%2520biotechnology%2520e-bulletin%2520September%25202009%2520(PDF%2520208Kb).pdf+phosphagenics+and+baker+idi&hl=en&gl=au&sig=AHIEtbRggG4qRcZ8q0hP2l51dIrRNWgIkQ
- Forums
- ASX - By Stock
- AVE
- grange for march
grange for march, page-24
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.635K | 1.045M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 93538418 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 60456317 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 93538418 | 0.002 |
19 | 68595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 60456317 | 21 |
0.004 | 17087707 | 16 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online